期刊文献+

新疆地区不同民族人群心房颤动与血清尿酸水平的相关性研究

Relationship between serum uric acid and atrial fibrillation in Uyghur and Han population of Xinjiang
下载PDF
导出
摘要 目的 探讨新疆地区维吾尔族、汉族心房颤动(AF)患者心房颤动的发生与血清尿酸水平的关系。方法 以维吾尔族、汉族心房颤动患者各100例作为病例组,以维吾尔族、汉族非心房颤动患者各100例作为对照组,记录各组患者的年龄、性别、尿酸水平,用药情况等。采用Logistic回归分析心房颤动发生的危险因素。结果 维吾尔族、汉族病例组与对照组比较,年龄、低密度脂蛋白、总胆固醇、尿酸水平差异有统计学意义(P〈0.05),心房颤动组年龄、低密度脂蛋白、总胆固醇和尿酸均显著高于非心房颤动组。多因素Logistic回归分析结果发现,年龄(OR=1.114,95%CI=1.080-1.149,P〈0.01)、总胆固醇(OR=1.902,95%CI=1.434-2.522,P〈0.01)和尿酸(OR=1.023,95%CI=1.017-1.029,P〈0.01)是心房颤动的独立危险因素。结论 在新疆地区维吾尔族和汉族人群中,血清尿酸可能是心房颤动的危险因素。 Objective To explore the relationship between serum uric acid and atrial fibrillation in Uyghur and Han population of Xinjiang. Methods One hundred Uyghur and 100 Han patients with atrial fibrillation were selected as case group, and 100 Uyghur and 100 Han subjects without atrial fibrillation were collected as control group. The baseline of clinical data were collected, including age, gender, risk factors of cardiology diseases, drugs and serum uric acid level. Risk factors of AF were analyzed by Logistic regression analysis. Results The age, low-density lipoprotein, total cholesterol and uric acid of patients with AF were significantly higher than those of control ( P 〈 0.05 ). Logistic regression analysis showed that the age ( OR = 1.114,95% CI = 1. 080 - 1. 149, P 〈 0. 01 ), total cholesterol ( OR = 1. 902, 95 % CI = 1. 434 - 2.522, P 〈 0.01 ), serum uric acid ( OR = 1. 023,95 % CI = 1. 017 - 1. 029, P 〈 0.01 )were risk factors for the occurrence of AF. Conclusion The serum uric acid is a risk factor of atrial fibrillation in Uyghur and Han population of Xinjiang.
出处 《中国临床保健杂志》 CAS 2016年第1期16-18,共3页 Chinese Journal of Clinical Healthcare
基金 国家自然科学基金(81260036)
关键词 心房颤动 尿酸 年龄因素 胆固醇 危险因素 Atrial fibrillation Uric acid Age factors Cholesterol Risk factors
  • 相关文献

参考文献14

  • 1Lippi G, Montagnana M, Franchini M, et al. The paradoxi- cal relationship between serum uric acid and cardiovascu- lar disease[J]. Clin Chim Acta,2008,392(1/2) : 1-7.
  • 2Numa S, Hirai T, Nakagawa K, et al. Hyperuricemia and transesophageal echocardiographic thromboembolic risk in patients with atrial fibrillation at clinically low - interme- diate risk[J]. Circ J,2014,78(7) : 1600-1605.
  • 3Sun GZ,Guo L,Wang J,et al. Association between hyperuri- cemia and atrial fibrillation in rural China: a cross-sectional study[J]. BMC Cardiovasc Disord,2015,15(1) : 98.
  • 4Suzuki S, Sagara K, Otsuka T, et al. Gender-specific rela- tionship between serum uric acid level and atrial fibrilla- tion prevalence[ J]. Circ J,2012,76(3) : 607-611.
  • 5Nyrnes A, Toft I, Njolstad I, et al. Uric acid is associated with future atrial fibrillation: an 11-year follow-up of 6308 men and women-the Tromso Study [ J ]. Eur opace, 2014, 16(3) : 320-326.
  • 6Mihm MJ, Yu F, Carnes CA, et al. Impaired myofibriHar energetics and oxidative injury during human atrial fibril- lation[J]. Circulation,2001,104(2) : 174-180.
  • 7张如森,林金秀.血清尿酸与高血压病患者心房颤动的关系[J].中国循环杂志,2013,28(6):434-437. 被引量:20
  • 8Karbowska A, Boratynska M, Kusztal M, et al. Hyperurice- mia is a mediator of endothelial dysfunction and inflam- mation in renal allograft recipients [ J ]. Transplant Proc, 2009,41 ( 8 ) : 3052-3055.
  • 9Pena JM, MacFadyen J, Glynn RJ, et al. High-sensitivity C-reactive protein, statin therapy, and risks of atrial fibril- lation: an exploratory analysis of the JUPITER trial [ J ]. Eur Heart J,2012,33(4) : 531-537.
  • 10Tamariz L, Agarwal S, Soliman EZ, et al. Association of se- rum uric acid with incident atrial fibrillation (from the Atherosclerosis Risk in Communities [ ARIC ] study) [ J ]. Am J Cardiol,2011,108(9) : 1272-1276.

二级参考文献38

  • 1胡大一,杨进刚.心房颤动的现代观点 (1)我国心房颤动流行概况和危害[J].中国循环杂志,2004,19(5):323-324. 被引量:40
  • 2顾水明,魏盟,张允平,薛晓培,张昀昀,吴韵华,侯晓峰,张卫兴,吴宗贵.血清尿酸水平与慢性心力衰竭心功能相关性研究[J].中国循环杂志,2004,19(5):359-362. 被引量:17
  • 3Van Wagoner DR.Oxidative stress and inflammation in atrial fibrillation:role in pathogenesis and potential as a therapeutic target.J Cardiovasc Pharmacol,2008,52:306-313.
  • 4Strazzullo P,Puig JG.Uric acid and oxidative stress:relative impact on cardiovascular risk?Nutr Metab Cardiovasc Dis,2007,17:409-414.
  • 5Karbowska A,Boratynska M,Kusztal M,et al.Hyperuricemia is a mediator of endothelial dysfunction and inflammation in renal allograft recipients.Transplant Proc,2009,41:3052-3055.
  • 6Sautin YY,Johnson RJ.Uric acid:the oxidant-antioxidant paradox.Nucleosides Nucleotides Nucleic Acids,2008,27:608-619.
  • 7Bagnati M,Perugnini C,Cau C,et al.When and why a watersoluble antioxidant becomes pro-oxidant during copper-induced low-density lipoprotein oxidation:a study using uric acid.Biochem J,1999,340:143-152.
  • 8Doehner W,Anker SD.Uric acid in chronic heart failure.Semin Nephrol,2005,25:61-66.
  • 9Letsas KP,Korantzopoulos P,Filippatos GS,et al.Uric acid elevation in atrial fibrillation.Hellenic J Cardiol,2010,51:209-213.
  • 10George J,Struthers AD.Role of urate,xanthine oxidase and the effects of allopurinol in vascular oxidative stress.Vasc Health Risk Manag,2009,5:265-272.

共引文献33

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部